tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MLYS Stock Latest News

Mineralys Therapeutics’ Earnings Call: Positive Outlook Amid Challenges
Company AnnouncementsMineralys Therapeutics’ Earnings Call: Positive Outlook Amid Challenges
4d ago
MLYS
Mineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
PremiumThe Fly
Mineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
5d ago
MLYS
3 Best Stocks to Buy Now, 5/14/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 5/14/2025, According to Top Analysts
5d ago
APP
MLYS
Strong Financial Position and Promising Clinical Results Support Buy Rating for Mineralys Therapeutics
PremiumRatings
Strong Financial Position and Promising Clinical Results Support Buy Rating for Mineralys Therapeutics
6d ago
MLYS
Positive Buy Rating for Lorundrostat Driven by Successful Trials and Future Potential
PremiumRatings
Positive Buy Rating for Lorundrostat Driven by Successful Trials and Future Potential
6d ago
MLYS
Optimistic Buy Rating for Mineralys Therapeutics Driven by Strategic Developments and Upcoming Data Releases
PremiumRatingsOptimistic Buy Rating for Mineralys Therapeutics Driven by Strategic Developments and Upcoming Data Releases
7d ago
MLYS
Mineralys Therapeutics Reports Strong Trial Results and Financial Growth
Premium
Company Announcements
Mineralys Therapeutics Reports Strong Trial Results and Financial Growth
7d ago
MLYS
Mineralys Therapeutics reports Q1 EPS (79c), consensus (98c)
Premium
The Fly
Mineralys Therapeutics reports Q1 EPS (79c), consensus (98c)
7d ago
MLYS
Mineralys Therapeutics, Inc. (MLYS) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Mineralys Therapeutics, Inc. (MLYS) Q1 Earnings Cheat Sheet
10d ago
MLYS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
18d ago
NVS
ABEO
Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study
PremiumThe Fly
Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study
26d ago
MLYS
Buy Rating Affirmed for Lorundrostat Amid Positive Trial Results and Market Potential
PremiumRatings
Buy Rating Affirmed for Lorundrostat Amid Positive Trial Results and Market Potential
2M ago
MLYS
Mineralys Therapeutics price target raised to $42 from $30 at H.C. Wainwright
PremiumThe FlyMineralys Therapeutics price target raised to $42 from $30 at H.C. Wainwright
2M ago
MLYS
3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts
2M ago
DAVE
ENVX
Mineralys Therapeutics Unveils Promising Trial Results for Lorundrostat
Premium
Company Announcements
Mineralys Therapeutics Unveils Promising Trial Results for Lorundrostat
2M ago
8K
MLYS
3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
2M ago
TLN
BRZE
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
PremiumThe Fly
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
2M ago
MLYS
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
PremiumRatings
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
2M ago
MLYS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
INO
ARCT
Buy Rating Justified for Mineralys Therapeutics, Inc. Due to Promising Study Results and Manageable Safety Profile
PremiumRatingsBuy Rating Justified for Mineralys Therapeutics, Inc. Due to Promising Study Results and Manageable Safety Profile
2M ago
MLYS
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
LAC
QSR
Mineralys Therapeutics announces data from Phase 2 Advance-HTN trial
Premium
The Fly
Mineralys Therapeutics announces data from Phase 2 Advance-HTN trial
2M ago
MLYS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >